Who may be considered
Adults who meet an FDA-approved medication’s eligibility criteria may be considered. The visit also helps people who are not candidates understand safer alternatives.
Home / Treatment Library / GLP-1 Weight-Loss Consultation
Medical weight management
GLP-1 Weight-Loss Consultation
A medical decision—not a medication checkout. A clear, evidence-aware guide to candidacy, treatment, recovery, limitations and next steps.
Evidence reviewed September 3, 2026
SettingIn-office + eligible telehealth
PricingConsultation required
Provider reviewIndividualized
Healthy change
A plan built around your body—not a template
Physician-led guidance brings your goals, health history and realistic expectations into one thoughtful plan.
The short answer
What is GLP-1 Weight-Loss Consultation?
A GLP-1 consultation determines whether prescription weight-management treatment is appropriate and which option, if any, best fits your health, goals, risks, access and preferences. It includes diagnosis, medication review, source verification, nutrition and a monitoring plan.
Concerns it may address
- Repeated weight regain or difficulty achieving clinically meaningful loss
- Obesity-related blood pressure, lipid, glucose, sleep or joint concerns
- Questions about semaglutide, tirzepatide, orforglipron or other FDA-approved medications
- Side effects, plateaus or transition from an unapproved product
Candidacy
Who may—or may not—be a candidate
When treatment may not be appropriate
A consultation may identify pregnancy, contraindicated thyroid history, severe gastrointestinal disease, pancreatitis or gallbladder risk, eating disorder, medication interaction or another issue that changes or postpones treatment.
At a glance
Treatment facts
These are practical planning ranges, not promises. Your consultation determines the exact plan.
- Treatment time
- Usually 30–60 minutes
- Comfort / anesthesia
- Conversation and examination; labs may be ordered
- Typical downtime
- None
- When changes may appear
- A plan can begin after evaluation and necessary records or labs
- How long results may last
- Ongoing monitoring is typically needed
- Treatments commonly considered
- Initial consultation plus scheduled follow-up
Your visit
What happens during treatment
Evaluate
We review weight trajectory, prior treatments, nutrition, activity, sleep, medications, pregnancy plans and medical conditions.
Plan & treat
The clinician determines whether testing, records, primary-care coordination or another diagnosis is needed.
Review & follow up
Options, product sourcing, expected benefits, side effects, cost and monitoring are compared. Prescription is issued only when clinically appropriate.
Informed choice
Important risks, limitations and alternatives
Risks & limitations
The main risk of skipping a complete assessment is receiving the wrong drug, dose or source. GLP-1 medicines have gastrointestinal and serious medical risks, and counterfeit or unapproved versions can add dosing and quality hazards.
Alternatives to discuss
- Structured nutrition and behavioral treatment
- Non-GLP-1 FDA-approved anti-obesity medication
- Management of sleep, endocrine or medication-related contributors
- Bariatric-medicine or surgical referral
Clinical judgment
Why provider experience matters
Obesity is a chronic medical condition, not a willpower problem. Experienced physician-supervised care addresses contraindications, comorbidities, lean-mass preservation, realistic rate of change and long-term maintenance.
Identity Aesthetics approach
- Diagnosis and anatomy before a product or device
- Conservative planning with candid limitations
- Licensed-provider supervision and complication readiness
- In-office and telehealth boundaries stated clearly
Access & cost
In-office versus telehealth
Available in-office and by telehealth for patients physically located in Texas, North Carolina or South Carolina, subject to law and clinical appropriateness. Labs or an in-person exam may be required.
Pricing: Consultation required. Visit, laboratory and medication costs are discussed before treatment; insurance and pharmacy coverage vary.
Medication transparency
Verify the pharmacy before treatment
When a prescription or compounded preparation is clinically appropriate, the dispensing pharmacy, facility classification and current license status matter. Compounded medications are not FDA-approved drug products.
Common questions
GLP-1 Weight-Loss Consultation FAQ
Will I receive a prescription at the first visit?
Only if the clinician has enough information and treatment is appropriate. Records, labs or additional evaluation may be needed first.
Do you guarantee a specific medication?
No. The purpose of the visit is to determine the safest option, which may be a different medication or no medication.
Can the entire program be telehealth?
Many visits may be virtual in eligible states, but local labs, vital signs, examination or referral may be needed.
Sources & medical review
- FDA Prescribing Information — Wegovy (semaglutide)
- FDA Prescribing Information — Zepbound (tirzepatide)
- FDA Prescribing Information — Foundayo (orforglipron)
- FDA — Concerns With Unapproved GLP-1 Drugs Used for Weight Loss
Medical-content evidence review: September 3, 2026. Content is written for patient education and structured from current primary regulatory, labeling and professional sources. It has not been individualized to your medical history. Product labeling and guidance can change; a licensed Identity Aesthetics provider confirms current suitability, informed consent and treatment details before care.
Your next step
Make an informed plan
Bring your goals, questions, medication list and prior treatment history. We will help you decide whether GLP-1 Weight-Loss Consultation—or an alternative—makes sense.